Overview

A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food

Status:
COMPLETED
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to investigate two different formulations of nerandomilast and the effect of food on the pharmakokinetics of the new formulation following oral administration.
Phase:
PHASE1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
BI 1015550